Sisram Medical (1696) Announces Third Quarter 2025 Business Update

Bulletin Express10-28

According to the voluntary announcement by Sisram Medical (the “Company”) and its subsidiaries (collectively, the “Group”), new orders maintained strong momentum in the third quarter of 2025, primarily driven by demand in China, South Korea, and Thailand. The Group’s flagship multi-modal platform, Alma Harmony, saw a solid increase in system orders during the quarter, contributing to double-digit year-on-year revenue growth based on unaudited figures.

The Group’s update indicates plans to continue expanding the deployment of the Soprano family in the Asia-Pacific region and expanding sales of Universkin by Alma in the United States. In addition, preparations for the upcoming DAXXIFY launch in Mainland China remain on track.

The announcement emphasizes that financial data provided is based on a preliminary review of unaudited results and advises caution when interpreting the figures.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104354939?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-28 20:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104354939","market":"us","top_or_hot":-1,"title":"Sisram Medical (1696) Announces Third Quarter 2025 Business Update","media":"Bulletin Express","content":"<p>According to the voluntary announcement by Sisram Medical (the “Company”) and its subsidiaries (collectively, the “Group”), new orders maintained strong momentum in the third quarter of 2025, primarily driven by demand in China, South Korea, and Thailand. The Group’s flagship multi-modal platform, Alma Harmony, saw a solid increase in system orders during the quarter, contributing to double-digit year-on-year revenue growth based on unaudited figures.</p>\n<p>The Group’s update indicates plans to continue expanding the deployment of the Soprano family in the Asia-Pacific region and expanding sales of Universkin by Alma in the United States. In addition, preparations for the upcoming DAXXIFY launch in Mainland China remain on track.</p>\n<p>The announcement emphasizes that financial data provided is based on a preliminary review of unaudited results and advises caution when interpreting the figures.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sisram Medical (1696) Announces Third Quarter 2025 Business Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSisram Medical (1696) Announces Third Quarter 2025 Business Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-28 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the voluntary announcement by Sisram Medical (the “Company”) and its subsidiaries (collectively, the “Group”), new orders maintained strong momentum in the third quarter of 2025, primarily driven by demand in China, South Korea, and Thailand. The Group’s flagship multi-modal platform, Alma Harmony, saw a solid increase in system orders during the quarter, contributing to double-digit year-on-year revenue growth based on unaudited figures.</p>\n<p>The Group’s update indicates plans to continue expanding the deployment of the Soprano family in the Asia-Pacific region and expanding sales of Universkin by Alma in the United States. In addition, preparations for the upcoming DAXXIFY launch in Mainland China remain on track.</p>\n<p>The announcement emphasizes that financial data provided is based on a preliminary review of unaudited results and advises caution when interpreting the figures.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"复锐医疗科技","start_time":0,"source_url":"","article_id":"1104354939","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104354939","pubTimestamp":1761653216,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"According to the voluntary announcement by Sisram Medical (the “Company”) and its subsidiaries (collectively, the “Group”), new orders maintained strong momentum in the third quarter of 2025,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技"},"translate_title":"Sisram Medical(1696)公布2025年第三季度业务更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":1},"content_text":"According to the voluntary announcement by Sisram Medical (the “Company”) and its subsidiaries (collectively, the “Group”), new orders maintained strong momentum in the third quarter of 2025, primarily driven by demand in China, South Korea, and Thailand. The Group’s flagship multi-modal platform, Alma Harmony, saw a solid increase in system orders during the quarter, contributing to double-digit year-on-year revenue growth based on unaudited figures.\nThe Group’s update indicates plans to continue expanding the deployment of the Soprano family in the Asia-Pacific region and expanding sales of Universkin by Alma in the United States. In addition, preparations for the upcoming DAXXIFY launch in Mainland China remain on track.\nThe announcement emphasizes that financial data provided is based on a preliminary review of unaudited results and advises caution when interpreting the figures.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104354939","isCrawlerRequest":true}